mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |